Plassche Douglas sold ELTP
October 2, 2025 · Form 4 insider transaction
Plassche Douglas sold 800,000 shares of Elite Pharmaceuticals, Inc. at $0.62 per share, a transaction worth $499.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
800,000
Price
$0.62
Total value
$499.2K
InsiderPlassche Douglas
Role—
Securitycommon stock
Transaction codeS: Open-market sale
Transaction dateOctober 2, 2025
Filing dateOctober 3, 2025
Shares owned after3,500,000
OwnershipDirect
10b5-1 planNo
AmendedNo